Summary
SynCardia Systems, Inc. (SynCardia) designs, develops, manufactures, sells and implements cardiovascular devices. Its flagship product is the SynCardia temporary Total Artificial Heart, which was formally known as CardioWest Total Artificial Heart. The size and shape of the artificial heart is designed to fit in the space of the removed diseased ventricles. This product is used for the patients with end-stage biventricular failure and also serves as a bridge to human heart transplant. SynCardia's major customers include medical institutions and hospitals. SynCardia temporary Total Artificial Heart is FDA, Health Canada and CE approved and is instantly available at SynCardia Certified Centers. It sells its products in the US and the UK through its own distribution network. SynCardia is headquartered in Arizona, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company SynCardia Systems, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
SynCardia Systems, Inc. Company Snapshot 5
SynCardia Systems, Inc. Company Overview 5
Key Information 5
SynCardia Systems, Inc. Pipeline Products and Clinical Trials Overview 6
SynCardia Systems, Inc. – Pipeline Analysis Overview 8
Business Description 8
Key Facts 9
SynCardia Systems, Inc. - Major Products and Services 10
SynCardia Systems, Inc. Pipeline Products by Development Stage 11
SynCardia Systems, Inc. Clinical Trials by Trial Status 13
SynCardia Systems, Inc. Pipeline Products Overview 14
10cc Ventricular Assist Device 14
10cc Ventricular Assist Device Product Overview 14
30cc Ventricular Assist Device 15
30cc Ventricular Assist Device Product Overview 15
50cc Total Artificial Heart - Destination Therapy 16
50cc Total Artificial Heart - Destination Therapy Product Overview 16
50cc Total Artificial Heart - Pediatric Bridge To Transplant 17
50cc Total Artificial Heart - Pediatric Bridge To Transplant Product Overview 17
60cc Ventricular Assist Device 18
60cc Ventricular Assist Device Product Overview 18
Companion Driver System 19
Companion Driver System Product Overview 19
Freedom Portable Driver 20
Freedom Portable Driver Product Overview 20
Freedom Portable Driver Clinical Trial 21
SynCardia Systems, Inc. - Key Competitors 22
SynCardia Systems, Inc. - Key Employees 23
SynCardia Systems, Inc. - Key Employee Biographies 24
SynCardia Systems, Inc. - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
SynCardia Systems, Inc., Recent Developments 26
Mar 18, 2014: SynCardia Total Artificial Heart Could Become the Life-Saving Answer to Heart Transplant Graft Failure 26
Mar 11, 2014: New Smaller SynCardia Total Artificial Heart Will Expand Life-Saving Therapy to All Adults & Many Adolescents 26
Feb 18, 2014: Edison Awards Selects SynCardia's Freedom Portable Driver As a 2014 Innovation Finalist 27
Feb 11, 2014: Turkey's Best Heart Hospitals Implant 25 Total Artificial Hearts in 40 Months 28
Feb 05, 2014: Carolinas HealthCare System Becomes the First to Implant the Total Artificial Heart in the Carolinas 29
Jan 07, 2014: New Record of 161 SynCardia Total Artificial Heart Implants Set in 2013 29
Dec 10, 2013: SynCardia Hits Record-Setting 150th Implant of the Total Artificial Heart in 2013 30
Nov 19, 2013: SynCardia Total Artificial Heart Makes Maryland Man Strong for His Ailing Wife 30
Nov 12, 2013: 1,200th Worldwide Implant of the SynCardia Total Artificial Heart Occurs in Indiana 31
Nov 05, 2013: Bridge to Transplant Patients Should Not Suffer from End-stage Biventricular Failure 32
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
List Of Tables
List of Tables
SynCardia Systems, Inc., Key Facts 5
SynCardia Systems, Inc. Pipeline Products and Clinical Trials Overview 6
SynCardia Systems, Inc. Pipeline Products by Equipment Type 6
SynCardia Systems, Inc. Pipeline Products by Indication 7
SynCardia Systems, Inc. Clinical Trials by Trial Status 7
SynCardia Systems, Inc., Key Facts 9
SynCardia Systems, Inc., Major Products and Services 10
SynCardia Systems, Inc. Number of Pipeline Products by Development Stage 11
SynCardia Systems, Inc. Pipeline Products Summary by Development Stage 12
SynCardia Systems, Inc. Clinical Trials by Trial Status 13
SynCardia Systems, Inc. Clinical Trials Summary 13
10cc Ventricular Assist Device - Product Status 14
10cc Ventricular Assist Device - Product Description 14
30cc Ventricular Assist Device - Product Status 15
30cc Ventricular Assist Device - Product Description 15
50cc Total Artificial Heart - Destination Therapy - Product Status 16
50cc Total Artificial Heart - Destination Therapy - Product Description 16
50cc Total Artificial Heart - Pediatric Bridge To Transplant - Product Status 17
50cc Total Artificial Heart - Pediatric Bridge To Transplant - Product Description 17
60cc Ventricular Assist Device - Product Status 18
60cc Ventricular Assist Device - Product Description 18
Companion Driver System - Product Status 19
Companion Driver System - Product Description 19
Freedom Portable Driver - Product Status 20
Freedom Portable Driver - Product Description 20
Freedom Portable Driver - SynCardia Freedom Driver System Study 21
SynCardia Systems, Inc., Key Employees 23
SynCardia Systems, Inc., Key Employee Biographies 24
SynCardia Systems, Inc., Subsidiaries 25
List Of Figures
List of Figures
SynCardia Systems, Inc. Pipeline Products by Equipment Type 6
SynCardia Systems, Inc. Pipeline Products by Development Stage 11
SynCardia Systems, Inc. Clinical Trials by Trial Status 13
